About
Founded in 2002, SCP Vitalife Partners is a venture capital firm focused on life science investments in Israel and the U.S. With $230 million under management in two funds, SCP Vitalife has made more than 30 investments in life sciences start-ups. They invest in companies with break-through products that address a current medical need and that are protected by strong IP. With offices in Tel-Aviv and Philadelphia, their team includes seasoned professionals with backgrounds as entrepreneurs, senior operating executives, clinical practitioners and technologists. SCP Vitalife allocates over half of its investment capital to investments in Israeli companies, or to companies that have significant R&D and operational ties to Israel. The remainder of the Fund's investment capital is allocated to companies based in the U.S.
Portfolio
Investment activity
Portfolio by sector
Q&A
- What is Vitalife's primary investment focus?
- Vitalife primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and investment rounds concentrated in this area.
- Can you name a notable company in Vitalife's portfolio?
- One notable company in Vitalife's portfolio is Sensible Medical Innovations, which specializes in noninvasive lung fluid monitoring and management.
- What is the funding stage of Sensible Medical Innovations?
- Sensible Medical Innovations is in the Mature funding stage and has raised $37.56M.
- When did Vitalife make its investment in Sensible Medical Innovations?
- Vitalife invested in Sensible Medical Innovations in June 2009, which was an A Round.
- What is Vitalife's typical investment stage?
- Vitalife has participated in A Round investments, as seen with Sensible Medical Innovations.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2002 |
|---|
Radar intelligence
Patents
| EPO | 74 |
|---|
Publications (Crossref)
| Works | 7 |
|---|